Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuromuscular Retraining vs Chemodenervation for Synkinesis
NCT04148872Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Synkinesis (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Sunnybrook Facial Grading System at 8 months. Started Oct 2019; status: completed.
02
Conditions
Synkinesis
Beyond the preview
Go deeper on NCT04148872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148872.